15 Immunomodulation by mesenchymal stem cells – a potential therapeutic strategy for type 1 diabetes

Kapitel in diesem Buch

1. Frontmatter i
2. Preface v
3. Contributing authors vii
4. Table of Contents xi
5. 1 Mesenchymal stem cells in the context of stem cell biology 1
6. 2 Are mesenchymal stem cells immune privileged? 17
7. 3 Mesenchymal stem cell therapies for autoimmune diseases 37
8. 4 Mesenchymal stem cells in osteoarthritis and rheumatic disease 51
9. 5 Mesenchymal stem cells in enthesis formation and repair 83
10. 6 Mesenchymal stem cells for clinical/therapeutic interventions of graft-versus-host disease 101
11. 7 Mesenchymal stem cells for graft-versus-host disease in experimental animal models 125
12. 8 Mesenchymal stem cells and organ transplantation : initial clinical results 143
13. 9 Stem cell therapy in patients with ischemic heart disease 163
14. 10 Mesenchymal stem cells as a strategy for the treatment of multiple sclerosis and other diseases of the central nervous system 185
15. 11 Mesenchymal stem cells for the treatment of inflammatory bowel disease 211
16. 12 Mesenchymal stem cells in chronic lung diseases: COPD and lung fibrosis 233
17. 13 Mesenchymal stem cells as therapeutics for liver repair and regeneration 263
18. 14 Mesenchymal stem cells attenuate renal fibrosis 293
19. 15 Immunomodulation by mesenchymal stem cells – a potential therapeutic strategy for type 1 diabetes 309
20. 16 Fibrogenic potential of human multipotent mesenchymal stem cells in inflammatory environments 319
21. 17 Mesenchymal stem cells and the tumor microenvironment 331
22. 18 Mesenchymal stem cells as a carrier for tumor-targeting therapeutics 353
23. 19 Systems biology approach to stem cells, tissues and inflammation 381
24. Index 395